Skip to main content
Ozge Ozden Tok on Muck Rack

Ozge Ozden Tok

As seen in: Clinical and Applied Thrombosis/Hemostasis, International Journal of Cardiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ozge Ozden

Contact Ozge Ozden, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A phenomenon to keep in mind in the imaging of peripheral arteries: Peripheral slow flow

|
By Ercan Akşit, Ozge Ozden Tok
| International Journal of Cardiology Verified
Ercan Akşit Ercan Akşit Correspondence Corresponding author at: Barbaros Street Terzioglu Campus B Block No: 4, Onsekiz Mart University Faculty of Medicine, Department of Cardiology, Canakkale, Turkey. Affiliations Canakkale Onsekiz Mart University Faculty of Medicine, Department of Cardiology, Canakkale, Turkey Search for articles by this author Özge Özden Tok
Open in Who Shared Issue with article?

The Trends in Utilizing Nonvitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation

|
By Cerrahpasa Faculty, Burcak Kilickiran Avci, Bulent Vatan, Ozge Ozden Tok
| Clinical and Applied Thrombosis/Hemostasis Verified
Dabigatran and rivaroxaban are novel nonvitamin K antagonist oral anticoagulants (NOACs) approved for thromboprophylaxis in atrial fibrillation (AF). In Turkey, like other countries, the efficacy of translation of the clinical trial results and current guideline recommendations into daily clinical practice is yet to be discovered. Using data from medical records of three tertiary care cardiology centers, we identified patients with nonvalvular AF on dabigatran or rivaroxaban treatment.
Open in Who Shared Issue with article?
See all 2 articles